ArticlePharmaceuticals (Basel, Switzerland)2024

Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus.

Shatha M Alobaid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.